Purchase Order HHSN268201700201A

<p>The National Heart Lung and Blood Institute awarded a purchase order to Covaris, LLC for $4,500.00 on July 21, 2011, with ultimate completion on July 20, 2012. The order covers a TAS Full Annual Service Plan for S-Series equipment on a firm fixed-price basis. Place of performance is Bethesda, Maryland. Covaris is a small business concern specializing in genomic research equipment and technologies.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Covaris, LLC for a Covaris LE220-PLUS Focused-Ultrasonicator (E220 upgrade) valued at $52,580 with an award date of August 28, 2018. Performance is located in Woburn, Massachusetts. The order carries a firm fixed price structure with an ultimate completion date of October 12, 2018. The underlying solicitation was posted July 23, 2018 with a due date of July 30, 2018.</p>

The Department of Health and Human Services' National Institutes of Health National Heart, Lung and Blood Institute awarded a $50,425 purchase order to Covaris, Inc.'s Covaris LLC Division. The firm fixed price contract is for a TAS high performance sampling instrument to be delivered between August and December 2010 at the prime contractor's place of performance in Bethesda, Maryland. No major subcontractors or set aside designations were indicated. The sampling instrument will support the...

This firm-fixed-price purchase order from the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), awarded Covaris, LLC $181,340.00 to upgrade and expand their ultrasonicator systems. Covaris is a for-profit manufacturer of genomics equipment and services, and has received numerous NIH and other federal agency contracts to supply focused-ultrasonicator instruments, accessories, and maintenance. This award did not have a small business set-aside...

This is a $89,747.51 firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Covaris, LLC for the delivery of a /E220 FOCUSED-ULTRASONICATOR SYSTEM. The contract has no set-aside designation. Covaris, LLC is a for-profit manufacturer of advanced genomic research tools and technologies, including the Adaptive Focused Acoustics (AFA) ultrasonicator instruments supplied under this award. The ultrasonicator...

<p>The National Human Genome Research Institute awarded a purchase order to Covaris, LLC for $6,375.00 on June 18, 2018. The order is firm fixed price with no set-aside designation and an ultimate completion date of January 1, 2019. Place of performance is North Bethesda, Maryland. The source does not specify the items or services being procured.</p>

The National Human Genome Research Institute awarded a purchase order to Covaris, LLC valued at $21,833.00 on July 13, 2018, for genomic research equipment and technologies. Performance is located in North Bethesda, Maryland, with an ultimate completion date of August 12, 2018. The order is firm fixed price with no small business set-aside designation. Covaris manufactures specialized laboratory instrumentation including focused ultrasonicator instruments and associated accessories for DNA and...

<p>The National Institutes of Health awarded a purchase order to Covaris, LLC for $35,372.00 on July 15, 2019 for supply and installation of a Covaris S220 focused ultrasonicator. Place of performance is Woburn, Massachusetts. The order carries firm fixed pricing with an ultimate completion date of September 10, 2019.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Covaris, LLC valued at $21,480 on July 12, 2018. Work is performed at North Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of August 11, 2018. No set-aside applies.</p>

The National Human Genome Research Institute awarded a purchase order to Covaris, LLC for a one-year service plan covering LE220-PLUS equipment (serial number 3388 and WCS 5177) with a ceiling value of $17,255.00, awarded May 7, 2020, with performance through July 1, 2021. Place of performance is Woburn, Massachusetts. The order is firm-fixed-price with no set-aside designation. Covaris is a small business concern specializing in genomic research instrumentation and associated maintenance and...